Biotech Values

[MinnieM]

AXON - Does anyone happen to have a link handy showing results of the ph II trial mentioned here?

http://axovant.com/clinical-trials/mindset-trial/

The MINDSET Phase 3 trial is designed to confirm the results of a 684-patient international, multi-center, double-blind placebo-controlled study in which patients on a stable background of donepezil therapy receiving 35 mg intepirdine demonstrated statistically significant improvements on the ADAS-cog and ADCS-ADL as compared to patients receiving donepezil alone.

I don't hold long or short, but, would like to understand the high valuation.